SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-032721
Filing Date
2023-02-10
Accepted
2023-02-10 16:40:05
Documents
1
Group Members
ARIX BIOSCIENCE HOLDINGS LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d438269dsc13da.htm SC 13D/A 46215
  Complete submission text file 0001193125-23-032721.txt   47718
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90696 | Film No.: 23612769
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Filed by) CIK: 0001700449 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A